KIR2DL5: an orphan inhibitory receptor displaying complex patterns of polymorphism and expression
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Cisneros, Elisaca
- dc.contributor.author Moraru, Manuelaca
- dc.contributor.author Gómez-Lozano, Nataliaca
- dc.contributor.author López-Botet, M. (Miguel)ca
- dc.contributor.author Vilches, Carlosca
- dc.date.accessioned 2015-06-08T08:49:57Z
- dc.date.available 2015-06-08T08:49:57Z
- dc.date.issued 2012ca
- dc.description.abstract A recently developed anti-KIR2DL5 (CD158f) antibody has demonstrated KIR2DL5 expression on the surface of NK and T lymphocytes, making it the last functional KIR identified in the human genome. KIR2DL5 belongs to an ancestral lineage of KIR with Ig-like domains of the D0-D2 type, of which KIR2DL4, an HLA-G receptor, is the only other human member. Despite KIR2DL4 and KIR2DL5 being encoded by genes with similar domain usage, several KIR2DL5 functions resemble more closely those of KIR recognizing classical HLA class I molecules – surface-expressed KIR2DL5 inhibits NK cells through the SHP-2 phosphatase and displays a clonal distribution on NK and T lymphocytes. No activating homolog of KIR2DL5 has been described in any species. The genetics of KIR2DL5 is complicated by duplication of its gene in an ancestor of modern humans living ∼1.7 million years ago. Both KIR2DL5 paralogs have undergone allelic diversification; the centromeric gene is most often represented by alleles whose expression is silenced epigenetically through DNA methylation, thus providing a natural system to investigate the regulation of KIR transcription. The role of KIR2DL5 in immunity is not completely understood, in spite of different attempts to define its ligand. Here we revisit the most relevant characteristics of KIR2DL5, an NK-cell receptor possessing a unique combination of genetic, structural, and functional features.en
- dc.description.sponsorship Research on KIR2DL5 was supported by successive grants from the Spanish Instituto de Salud Carlos III and Plan Nacional de I + D, including SAF2010-22153-C03.en
- dc.format.mimetype application/pdfca
- dc.identifier.citation Cisneros E, Moraru M, Gómez-Lozano N, López-Botet M, Vilches C. KIR2DL5: an orphan inhibitory receptor displaying complex patterns of polymorphism and expression. Front Immunol. 2012;3:289. DOI: 10.3389/fimmu.2012.00289ca
- dc.identifier.doi http://dx.doi.org/10.3389/fimmu.2012.00289
- dc.identifier.issn 1664-3224ca
- dc.identifier.uri http://hdl.handle.net/10230/23760
- dc.language.iso engca
- dc.publisher Frontiersca
- dc.relation.ispartof Frontiers in Immunology. 2012;3:289
- dc.relation.projectID info:eu-repo/grantAgreement/ES/3PN/SAF2010-22153
- dc.rights © 2012 Cisneros, Moraru, Gómez-Lozano, López-Botet and Vilches. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.ca
- dc.rights.accessRights info:eu-repo/semantics/openAccessca
- dc.rights.uri https://creativecommons.org/licenses/by/3.0/
- dc.subject.keyword Gene polymorphismen
- dc.subject.keyword Human NK cellsen
- dc.subject.keyword Inhibitory receptorsen
- dc.subject.keyword KIRen
- dc.subject.keyword NK cell receptorsen
- dc.subject.other Receptors cel·lularsca
- dc.subject.other Cèl·lules citotòxiquesca
- dc.title KIR2DL5: an orphan inhibitory receptor displaying complex patterns of polymorphism and expressionca
- dc.type info:eu-repo/semantics/articleca
- dc.type.version info:eu-repo/semantics/publishedVersionca